Small studies indicate Moderna COVID-19 vaccine may be effective against Delta, Kappa and Eta variants

Moderna, Inc. released a clinical update of a small Phase 1 trial this week evaluating the performance of its mRNA COVID-19 vaccine against three of the ever-multiplying strains of the disease, including the worrisome Delta variant.

Based on serum samples from eight vaccinated participants, neutralizing titers were produced against the Beta, Kappa, Delta, Eta, A.23.1, and A.VOI.V2 variants of SARS-CoV-2 — the virus that causes COVID-19. Results were submitted as a preprint to bioRxiv.

“As we seek to defeat the pandemic, it is imperative that we are proactive as the virus evolves. We remain committed to studying emerging variants, generating data, and sharing it as it becomes available. These new data are encouraging and reinforce our belief that the Moderna COVID-19 Vaccine should remain protective against newly detected variants,” Stéphane Bancel, CEO of Moderna, said. “These findings highlight the importance of continuing to vaccinate populations with an effective primary series vaccine.”

While clinical trials have been conducted against other strains, this test focused on these additional variant strains. While minimal reduction to neutralizing titers was observed on the Alpha and A.23.1 strains, a modest reduction was observed in Delta (2.1-fold), Gamma (3.2-fold), Kappa (3.3-3.4-fold), and Eta (4.2-fold). The Beta variant brought anywhere from a 7.3-8.4-fold reduction in neutralizers, but the biggest reduction outright was encountered in A.VOI.V2, which brought an 8-fold reduction.

At present, A.VOI.V2 — first identified in Angola — is not designated as a variant of concern or interest.

Chris Galford

Recent Posts

House Homeland Security Republicans urge updates on Chinese threats to information and communications tech

In a letter sent to Cybersecurity and Infrastructure Security Agency (CISA) Director Jen Easterly this…

3 days ago

Legislation targets enhanced natural disaster preparedness, response

U.S. Reps. Eric Swalwell (D-CA) and Jenniffer González-Colón (R-PR) are espousing the benefits of newly…

3 days ago

Northrop Grumman outlines progress of Next Generation Overhead Persistent Infrared Polar program

Northrop Grumman Corporation officials have noted the aerospace company has completed a Preliminary Design Review…

3 days ago

Agencies tout updated ransomware reduction resource

Four agencies are espousing the benefits of a newly published updated resource they indicated seeks…

4 days ago

DHS S&T details RIVTD Track 2 launch

U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T) officials have outlined the…

4 days ago

Proposed update to federal Dignity Act targets illegal immigration, American economy

As a wide-ranging proposal to revise the United States immigration system, U.S. Reps. Maria Elvira…

4 days ago

This website uses cookies.